%A Wang,Zhefang %A Liu,Fanyu %A Fan,Ningbo %A Zhou,Chenghui %A Li,Dai %A Macvicar,Thomas %A Dong,Qiongzhu %A Bruns,Christiane J. %A Zhao,Yue %D 2020 %J Frontiers in Oncology %C %F %G English %K Glutaminolysis,Cancer Metabolism,metastasis,Glutaminase inhibitor,combination therapy %Q %R 10.3389/fonc.2020.589508 %W %L %M %P %7 %8 2020-October-26 %9 Review %+ Yue Zhao,Department of General, Visceral, Tumor and Transplantation Surgery, University Hospital Cologne,Germany,yue.zhao@uk-koeln.de %# %! Targeting glutaminolysis in cancer metabolism %* %< %T Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies %U https://www.frontiersin.org/articles/10.3389/fonc.2020.589508 %V 10 %0 JOURNAL ARTICLE %@ 2234-943X %X Metabolism rewiring is an important hallmark of cancers. Being one of the most abundant free amino acids in the human blood, glutamine supports bioenergetics and biosynthesis, tumor growth, and the production of antioxidants through glutaminolysis in cancers. In glutamine dependent cancer cells, more than half of the tricarboxylic/critic acid (TCA) metabolites are derived from glutamine. Glutaminolysis controls the process of converting glutamine into TCA cycle metabolites through the regulation of multiple enzymes, among which the glutaminase shows the importance as the very first step in this process. Targeting glutaminolysis via glutaminase inhibition emerges as a promising strategy to disrupt cancer metabolism and tumor progression. Here, we review the regulation of glutaminase and the role of glutaminase in cancer metabolism and metastasis. Furthermore, we highlight the glutaminase inhibitor based metabolic therapy strategy and their potential applications in clinical scenarios.